Breast Cancer Clinical Trial
Official title:
A Prospective, Randomized Controlled Trial of Mindfulness-based Stress Reduction (MBSR) Among Women Operated for Breast Cancer
The number of Danish women treated for breast cancer rise every year, though survival rates
have improved, women can still expect to experience the diverse late effects reported by
this group of patients. Mindfulness labels the ability to be aware of the present moment -
thereby avoiding speculations about both past and present. Mindfulness based
stress-reduction (MBSR) is an 8-week program, covering 24 contact-hours and 45 minutes daily
home practice. The program aims at developing participants' coping resources and developing
participants' mindful awareness. Thus the program consists of guided meditations, guided
body scan(a specific awareness exercise)and through meditation, yoga and psychoeducation
concerning stress and stress-reactions, while meditation and bodyscan is practiced at home
by the use of specific audio-CDs guiding the patient. The MBSR-program have shoved promising
results among patients with anxiety-disorders, depression and chronic pain. Smaller studies
have also found positive effects of the program among cancer patients. The investigators
want to evaluate the effect of the MBSR program on levels of anxiety and depression as well
as the possible influence of mindfulness training on health behaviors and existential
concerns. The study are based on the following hypotheses:
- report of anxiety and depression will decrease among cases
- better compliance will lead to more decrease in levels of anxiety and depression
- cases will make lifestyle changes suitable with recommendations for BC patients in
post-treatment phase of the illness
- decreased level of anxiety and depression will reflect improved spiritual well-being
- improved spiritual wellbeing will lead to decreased report of physical symptoms
All participants in this randomized controlled trial will fill out questionnaires at
enrollment and as 1, 6 and 12 months follow-up. Based on results from this trial clinicians
and patients will be able to make decisions regarding post-treatment psychosocial
intervention and researchers will have initial evidence of the effect of the intervention
and thus possible indications for research on mindfulness among patients diagnosed with
cancer at other stages or sites.
Original Research Protocol, Copenhagen January 2007 Cancer and Mindfulness: A prospective,
randomized trial of a psychosocial intervention among women operated for breast cancer
Background From the time of diagnosis cancer patients have a need for psychological support.
Many patients handle the situation by the help of friends and family, while others need
professional support to come to terms with different phases of life as a cancer patient.
Only few randomized trials have been conducted in order to determine what kinds of
professional support patients will benefit from. These studies conclude that the prevalence
of anxiety and depression in reduced. This is of major importance as depending of cancer
type, treatment modality, age and gender, a total of 10-50 % of Danish cancer patients
reports such well-defined psychosocial symptoms following the diagnosis of cancer.
Mindfulness meditation aims to increase the experience of presence and an increased relation
to several emotional and sensory experiences. Instead of being a technique aimed to control
and change unwanted psychological states the method is rather a way to stay present in the
here and now without judging and as such it has been developed into a stress reduction
method: mindfulness based stress reduction (MBSR). The method is taught within a group
setting by an instructor guiding the patients during a week long program. The method has
been evaluated within a variety of settings and has been found to effectively reduce
symptoms related to different stress and pain conditions i.e. psoriasis, chronic pain,
HIV/AIDS, anxiety and depression.2 Based on these experiences several programs have been
developed and the program developed by Williams and Kabatt-Zinn has gained status as the
most commonly applied and best validated. Within recent years the program has been included
into cognitive-behavioral therapy. But with potential effects not only as reduction of
symptoms but further opens the opportunity for participants to approach spiritual and
existential themes. The potential effect is therefore not limited to simple reduction of
symptoms but includes increased meaningfulness, quality of life and sense of coherence.
Nine studies of the effect of MBSR haw been conducted, including 10- 157 adult cancer
patients being taught MBSR in groups of mainly breast cancer patients, but only three of
these trials have been conducted as randomized controlled trials. I these trials patients
have self-referred (selection bias), analysis have not been adjusted for biological status
of the cancer disease (confounding), samples have been small (n=10-157) (type 2 error) and
patients have differed with regard to time since diagnosis (misclassification). Despite
these methodological limitations a tendency of positive effects of MBSR participation on
psychological and physiological outcomes has been observed.
Yet it is still not determined whether MBSR will provide cancer patients benefit improving
their daily life with cancer. Some important aspects have not been addressed in previous
studies: When MBSR is applied as an intervention dose-response relation has only been
observed among patients with a moderate level of symptoms. Thus sensitivity of MBSR in
relation to stages of cancer, levels of pain or negative effects of treatments. We still do
not know whether all cancer patients will profit from this type of intervention. Further the
influence of patient compliance and working alliance is still not explored.
The diagnosis of cancer accentuates existential dimensions as spirituality and quality of
life. Yet we do not know how MBSR can support patients in dealing with such themes. Be
review of literature regarding patients coping with cancer the patients demand for
interventions supporting their need to deal with existential themes is striking.
Aim We will conduct a randomized controlled trial among women diagnosed with primary breast
cancer in order to evaluate the effect of MBSR on depression, anxiety quality of life,
health behavior and psychological well-being.
Research questions
- We do not know whether all types of cancer patients will benefit from MBSR. Especially
patients compliance must be empirically documented
- Cancer accentuates an array of existential concerns and the effect of MBSR on these
subjective concerns must be examined
Inclusion All patient diagnosed with primary breast cancer in Department of Breast Surgery,
Copenhagen Hospital Herlev, will be invited to participate in the study and in the
randomization allocating patients to either MBSR intervention or treatment as usual control.
Patients diagnosed and in active treatment for major psychiatric disease, patients with
musculoskeletal disease and cardiovascular disease hindering MBSR participation, and
patients previously diagnosed with other cancers than non-melanoma skin cancer will be
excluded. A project nurse will contact eligible patients, deliver oral and written
information and collect informed consent. If the patient consents baseline questionnaire
will be administered.
Randomization will then take place. The project nurse will up-load patient data on secured
project home-page. Computer generated sequence will automatically assign a unique study
number to each patient indicating which study group she is allocated to. Result of the
randomization will be delivered to the patient by the project nurse and potential
disappointment will be handles at this point, and information regarding optional counseling
provided by the Danish Cancer Society will also be given.
Intervention group MBSR will be delivered in groups of maximum 20 participants. The course
will follow an 8 week schedule with 2-2½ hour sessions each week and instruction to practice
45 minutes daily at home. Upon conclusion of the course each group will participate in a
full-day course (8 hours). The courses will be delivered by a manual (including audio CDs)
developed by Antonia Sumbundu (see attached file). The group must meet in a quiet room large
enough to room 20 persons lying down, as well as mats, carpets and chairs. The courses will
be delivered in locations not affiliated with a hospital.
Control group The control group will receive treatment as usual and thus follow the standard
control program applied by the surgical department.
- Questionnaire Prior to randomization and as follow-up after 6 and 12 months both study
groups will be mailed questionnaires containing validated psychometric
- Hospital charts Descriptions of breast cancer operation, pathology of tumor as well as
day to day entries will be collected.
- Administrative registries Data regarding comorbidity of all eligible patients will be
collected in National Patient Registry and Central Psychiatric Registry upon
finalization of the project.
- Qualitative outcomes Data collected by standardized self-report instruments will be
supplemented by qualitative interviews inviting the intervention group participants to
present themselves by giving an account of the treatment and a personal evaluation of
the potential benefit.
Analysis
- Quantitative data Data will be stores in a database at the institute. Logistic
regression analysis will be applied to evaluate which background variables effects
participation. Analysis of outcomes will be conducted by applying multiple regressions
at each time point. For simultaneous analysis of all follow-up times a linear mixed
model with random effects of persons will be fitted. Outcomes as relapse and death
among intervention group in comparison to both control group and non-participants will
be analyzed by use of Cox regression model, controlling for the effect of biological
and demographic variables. Analysis will be conducted under supervision of a senior
statistician at the Department of Statistics and Epidemiology at the Institute.
- Qualitative data Based on the qualitative interviews a set of data-driven categories
will be developed. These categories will be quantitatively evaluated. The transcript of
the patient's self-presentation (approximately 2 pages) will be analyzed by use of
qualitative methods, allowing for grouping of content categories as expressed by the
patients. Statistical analysis will be applied to evaluate these categories.
Ethics Application of permission to conduct the study will be submitted to the The National
Committee on Health Research Ethics and to the Danish Data Protection Agency. In information
to patients regarding the study it will be stressed that participation is voluntary and that
patients withdraw without any explanation at any time, and that withdrawal will have no
influence on treatments delivered. Both written and oral consent must be given prior to
participation. A short report will be mailed to all participants upon conclusion of the
study. Vital status of participants will be checked in Central Persons Registry prior to any
sending of study questionnaire. Data kept in the study database will be encrypted ensuring
that only authorized scientific staff will be able to identify individuals. The encryption
code will be kept by study manager. Results will be reported as tables and figures hindering
identification of individuals. Also in the reporting of qualitative data will the quoted
participants be kept anonymous.
Reference List
1. Ross L, Boesen E, Dalton S, Johansen C. Mind and cancer: does psychological
intervention improve suvival and psychological well-being? European Journal of Cancer
2001.
2. Ott MJ, Norris RL, Bauer-Wu SM. Mindfulness meditation for oncology patients: a
discussion and critical review. Integr Cancer Ther 2006; 5(2):98-108.
3. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in Breast
Cancer Survivors: Occurrence, Correlates, and Impact on Quality of Life. J Clin Oncol
2000; 18(4):743.
4. Bower JE, Ganz PA, Desmond KA et al. Fatigue in long-term breast carcinoma survivors: a
longitudinal investigation. Cancer 2006; 106(4):751-758.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |